Drug Profile
Progesterone - TherapeuticsMD
Alternative Names: TX-002HR; TX-005HR; TX-007HR; TX-12-002HRLatest Information Update: 25 Dec 2021
Price :
$50
*
At a glance
- Originator TherapeuticsMD
- Class Hormonal contraceptives; Hormonal replacements; Infertility therapies; Pregnenediones; Small molecules
- Mechanism of Action Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Suspended Amenorrhoea
Most Recent Events
- 04 Mar 2021 Preclinical development for Amenorrhoea is still suspended in USA (Topical) (TherapeuticsMD 10-K, March 2021)
- 04 Mar 2021 Preclinical development for Amenorrhoea is still suspended in USA (Transdermal) (TherapeuticsMD 10-K, March 2021)
- 28 Feb 2017 Suspended - Phase-I for Amenorrhoea in USA (Transdermal) (TherapeuticsMD 10-K, March 2017)